Osiris Therapeutics, Inc. (NASDAQ:OSIR)

CAPS Rating: 1 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Recs

0
Player Avatar Jmachine (< 20) Submitted: 9/14/2009 1:08:14 PM : Outperform Start Price: $7.87 OSIR Score: -47.07

I say it's time to get in on this stock.

Featured Broker Partners


Advertisement